Expression analysis revealed significant differences and upregulation of RPL36A in various tumours, including breast cancer, renal clear cell carcinoma, hepatocellular carcinoma, pancreatic cancer and lung cancer, compared to normal tissues. This evidence concerns the gene RPL36A and breast carcinoma.